EUVIMEDEUVIMED entdecken
Crossref

Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression

Yang Tan, Chi Cheng, Cong Zheng, Weiqi Zeng, Xiaoman Yang, Yu Xu, Zhaoyuan Zhang, Zhuoran Ma, Yan Xu, Xuebing Cao

Pharmacology Biochemistry and Behavior · 2023

DOI: 10.1016/j.pbb.2023.173637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2023. Verfasst von Yang Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China. Hauptthemen laut MEDLINE: Dyskinesia, Drug-Induced, Parkinsonian Disorders. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Group II metabotropic glutamate receptors (mGlu2/3 receptors) have been regarded as promising candidates for the treatment of L-DOPA-induced dyskinesia (LID); however, confirmation is still lacking. As the hub of the basal ganglia circuit, the striatum plays a critical role in action control. Supersensitive responsiveness of glutamatergic corticostriatal input may be the key mechanism for the development of LID. In this study, we first examined the potency of LY354740 (12 mg/kg, i.p.) in modulating glutamate and dopamine release in lesioned striatum of stable LID rats. Then, we injected LY354740 (20nmoL or 40nmoL in 4 μL of sterile 0.9 % saline) directly into the lesioned striatum to verify its ability to reduce or attenuate L-DOPA-induced abnormal involuntary movements. In experiment conducted in established LID rats, after continuous injection for 4 days, we found that LY354740 significantly reduced the expression of dyskinesia. In another experiment conducted in parkinsonism rat models, we found that LY354740 attenuated the development of LID with an inverted-U dose-response curve. The role of LY354740 in modulating striatal expressions of LID-related molecular changes was also assessed after these behavioral experiments. We found that LY354740 significantly inhibited abnormal expressions of p-Fyn/p-NMDA/p-ERK1/2/p-HistoneH3/ΔFosB, which is in line with its ability to alleviate abnormal involuntary movements in both LID expression and induction phase. Our study indicates that activation of striatal mGlu2/3 receptors can attenuate the development of dyskinesia in parkinsonism rats and provide some functional improvements in LID rats by inhibiting LID-related molecular changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dyskinesia, Drug-InducedParkinsonian DisordersRatsAnimalsLevodopaRats, Sprague-DawleyCorpus StriatumOxidopamineAntiparkinson AgentsDisease Models, AnimalBridged Bicyclo Compounds

Stichwörter der Autor:innen

Abnormal involuntary movementsL-DOPA-induced dyskinesiaMetabotropic glutamate receptorStriatumΔFosB

Substanzen

LevodopaOxidopamineAntiparkinson AgentseglumetadBridged Bicyclo Compounds

Autor:innen und Institutionen

  • Department of Neurology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China.
  • Department of Neurology, Hanchuan People's Hospital, 432300, China.
  • Institute of Neuroscience, Chinese Academy of Sciences, Shanghai 200000, China.
  • Department of Neurology, The First People's Hospital of Foshan, Foshan 528000, China.
  • Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.
  • Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China. Electronic address: caoxuebing@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Tan, Y., Cheng, C., Zheng, C., Zeng, W., Yang, X., Xu, Y., Zhang, Z., Ma, Z., Xu, Y., & Cao, X. (2023). Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2023.173637

Vancouver

Tan Y, Cheng C, Zheng C, Zeng W, Yang X, Xu Y, et al. Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression. Pharmacology Biochemistry and Behavior. 2023. doi:10.1016/j.pbb.2023.173637

BibTeX
@article{Tan2023,
  author = {Tan, Yang and Cheng, Chi and Zheng, Cong and Zeng, Weiqi and Yang, Xiaoman and Xu, Yu and Zhang, Zhaoyuan and Ma, Zhuoran and Xu, Yan and Cao, Xuebing},
  title = {Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2023},
  doi = {10.1016/j.pbb.2023.173637}
}
Kostenlos starten →